Please login to the form below

Not currently logged in
Email:
Password:

hepatic encephalopathy

This page shows the latest hepatic encephalopathy news and features for those working in and with pharma, biotech and healthcare.

FDA approves two new IBS medicines

FDA approves two new IBS medicines

coli  and for reduction of the risk in adult patients of recurring overt hepatic encephalopathy, the changes in brain function that occur when the liver is unable to remove toxins from

Latest news

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

Latest Intelligence

  • Pharma deals in February 2015 Pharma deals in February 2015

    Xifaxan is currently marketed for the treatment of hepatic encephalopathy and traveller's diarrhoea and nets $750m in sales, however, should the current FDA review for an inflammatory bowel disease with

  • Experience me: building engagement through experience Experience me: building engagement through experience

    It's a documentary. . It tackles the challenge of convincing clinicians of the impact that the condition hepatic encephalopathy (HE) has on patients and their families, and thus stresses the need

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics